Search
for
Sort by
Research 511–540 of 1000+
- Pernicious anemia in a patient with Type 1 diabetes mellitus and alopecia areata universalis
- Type 1 Diabetes Mellitus and Autoimmune Diseases: A Critical Review of the Association and the Application of Personalized Medicine
- Type 1 interferon signature and cytotoxic T lymphocyte activation targeted against sweat ducts in inflammatory acquired idiopathic generalized anhidrosis
- Effect of metformin on clinical and biochemical hyperandrogenism in adolescent girls with type 1 diabetes
- Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men.
- Expression of type 1 5α-reductase and metabolism of testosterone in reconstructed human epidermis (SkinEthic®): a new model for screening skin-targeted androgen modulators
- Proliferative diabetic retinopathy as onset of type 1 diabetes
- Co-occurrence of monilethrix and Type 1 diabetes mellitus
- Vitiligo and Alopecia Areata as Early Signs Preceding Type 1 Diabetes Mellitus
- Lipoprotein and inflammatory glycoprotein profiles in women with polycystic ovary syndrome alone or in association with type 1 diabetes
- Androgen excess disorders remain undiagnosed in one of every four premenopausal women with Type 1 diabetes
- A RARE CASE OF SIMULATANEOUS DEVELOPMENT OF ALOPECIA AREATA UNIVERSALIS AND TYPE 1 DIABETES MELLITUS
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Autoimmune disorders associated with type 1 diabetes: clinical overview and principles of management
- 1326 Translation-dependent skin hyperplasia is promoted by type 1/17 inflammation in psoriasis
- A Rare association of Mauriac syndrome and Van-Wyk Grumbach syndrome found in a young Saudi girl with poorly controlled type 1 Diabetes and Hypothyroidism: A Case Report and Brief literature review
- 943 Temporal-spatial activation of Wnt-signaling within Type1 / Type 2 immunity during wound healing
- Alterations of collagen type 1, skin fibroblasts, and macrophages in the scalp following the treatment of 1550‐nm erbium glass fractional laser for androgenetic alopecia
- Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Associations between type 1 diabetes and autoimmune skin diseases: Mendelian randomization analysis
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- The rare association of congenital glaucoma, giant melanocytic nevus, alopecia, and hypospadias in an Egyptian child with neurofibromatosis type 1: a case report
- Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management
- Successful topical minoxidil treatment for hair density and length in trichorhinophalangeal syndrome type 1
- Autoimmune polyendocrine syndrome type 1 a case report from Bangladesh
- Borate-modified recombinant type XVII collagen microneedles loaded with IGF-1 for the treatment of androgenetic alopecia
- Self-assembling peptide inspired by insulin and type 1 insulin-like growth factor for the treatment of androgenetic alopecia
- Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts.